Panagiotis Panotopoulos, M.D.
Cardiovascular Disease Physician in Mesa, Arizona. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers — including 24,795 in Cardiovascular Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration — see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Panagiotis Panotopoulos, M.D. reported a CMS MIPS final score of 95.1/100 — above the 83.1 national average — and filed 3,385 Medicare Part D claims in 2023.
- 95.1/100
- MIPS score · +12 vs avg
- 3K
- Part D claims, 2023
- 83%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
Panagiotis Panotopoulos, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
95 Top 21% higher than 79% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Panagiotis Panotopoulos, M.D. sits
This provider among cardiovascular disease physician peers
Across the 8,753 cardiovascular disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Panagiotis Panotopoulos, M.D. writes more Part D claims than 56% of them and scores higher on MIPS quality than 79% — placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one cardiovascular disease physician peer from a representative sample of 60; the gold marker is Panagiotis Panotopoulos, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Panagiotis Panotopoulos, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Panagiotis Panotopoulos, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Arizona
How Cardiovascular Disease Physician compares to other specialties among Arizona providers
Largest specialties in Arizona (% of in-state providers)
Cardiovascular Disease Physician ranks #51 among Arizona's specialties (0.4% of in-state providers)
Each bar is a specialty's share of the Arizona provider total, by primary NUCC taxonomy. The highlighted bar is Cardiovascular Disease Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance — MIPS
Panagiotis Panotopoulos, M.D.'s 2023 MIPS final score plotted against the Cardiovascular Disease Physician national average
- MIPS Final Score
- 95.1/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Cardiovascular Disease Physician) — 95.1/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Cardiovascular Disease Physician US NPIs
95.1/100 MIPS final score — 12.0 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Cardiovascular Disease Physician. Quality dim: 90.2.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Panagiotis Panotopoulos, M.D. appears in the CMS NPPES registry as a Cardiovascular Disease Physician provider holding M.D. credentials at 6116 E. ARBOR AVE, Mesa, AZ, 85206, with a listed phone of (480) 641-5400. NPI 1629023411 was issued on 05/23/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Panotopoulos most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 3,385 prescription claims written by this provider, covering 490 Medicare beneficiaries and totaling roughly $759K in drug spend, split 17% brand-name and 83% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 95.1/100 for the 2023 performance year (Quality 90.2), compared with the national average of 83.1.
Cardiovascular Disease Physician is a mid-sized specialty nationwide, with 24,795 enrolled providers across 54 states and an average of 3,033 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1629023411 |
|---|---|
| Specialty | Cardiovascular Disease Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 05/23/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Panagiotis Panotopoulos, M.D.'s current license status, disciplinary history, and board certifications with the Arizona Medical Board in Arizona before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Brand vs generic prescribing mix · Typical
17% brand-name claims vs 83% generic, on 3,385 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 9,462
- Total Day Supply
- 283,410
- Brand vs Generic
- 17% brand / 83% generic
- Brand Drug Cost
- $695K
- Generic Drug Cost
- $64K
Patient Demographics
- Average Patient Age
- 77.0 years
- Avg HCC Risk Score
- 1.84
- Gender Split
- 48% female / 52% male
- Age Distribution
- <65: 19, 65-74: 171, 75-84: 218, 85+: 82
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Panagiotis Panotopoulos, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Atorvastatin Calcium
Atorvastatin Calcium
366 claims
- Eliquis
Eliquis
319 claims
- Metoprolol Succinate
Metoprolol Succinate
252 claims
- Carvedilol
Carvedilol
195 claims
- Lisinopril
Lisinopril
170 claims
- Losartan Potassium
Losartan Potassium
167 claims
- Furosemide 146
Furosemide
146 claims
- Rosuvastatin Calcium 136
Rosuvastatin Calcium
136 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 366 |
| Eliquis Apixaban | 319 |
| Metoprolol Succinate | 252 |
| Carvedilol | 195 |
| Lisinopril | 170 |
| Losartan Potassium | 167 |
| Furosemide | 146 |
| Rosuvastatin Calcium | 136 |
| Amlodipine Besylate | 128 |
| Spironolactone | 89 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Cardiovascular Disease Physician Overview
How Panagiotis Panotopoulos, M.D. fits within the Cardiovascular Disease Physician landscape nationally.
Panagiotis Panotopoulos, M.D.'s 3,385 claims are above the specialty average of 3,033.
Nearby Cardiovascular Disease Physician Providers in Arizona
Other clinicians with the same primary specialty enrolled in Arizona, drawn from the same CMS NPPES roster as Panotopoulos.
Compare Cardiovascular Disease Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry — providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Arizona medical board — federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Cardiovascular Disease Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only — they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Arizona
Frequently Asked Questions
What is Panagiotis Panotopoulos, M.D.'s specialty? ▼
How much does Panagiotis Panotopoulos, M.D. prescribe under Medicare Part D? ▼
What is Panagiotis Panotopoulos, M.D.'s Medicare quality score? ▼
Where is Panagiotis Panotopoulos, M.D. located? ▼
What is Panagiotis Panotopoulos, M.D.'s NPI number? ▼
Does Panagiotis Panotopoulos, M.D. prescribe more brand-name or generic drugs? ▼
How many Cardiovascular Disease Physician providers are there in the US? ▼
What drugs does Panagiotis Panotopoulos, M.D. prescribe most often? ▼
Does Panagiotis Panotopoulos, M.D. accept Medicare? ▼
How can I verify Panagiotis Panotopoulos, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology